WVU Home
Search:DepartmentHealth Sciences CenterWVU  Go
West Virginia University, Robert C. Byrd Health Sciences Center A-Z WVU Site Index Campus Map WVU Directory Contact Us WVU Home School of Medicine
Addictive Medicine Research

The faculty members in the Addiction Services Program are involved in the development of new treatments and interventions for alcohol and drug dependence.

The research mission of this program is to conduct studies of behavioral, pharmacological and integrated behavioral and pharmacological treatment interventions in a clinical setting. Currently, faculty members in the addiction program are involved in multiple research projects and clinical trials. In addition, the department is a member of the Clinical Trials Network (CTN) of the National Institute of Drug Abuse which is a network for researchers and clinicians conducting multi-site community based studies regarding interventions for the drug-dependent population. In partnership with Western Psychiatric Institute and Clinic of the University of Pittsburgh, the department joined the Clinical Trials Network in 2005. The department along with three community treatment programs in Eastern Ohio and Western Pennsylvania and the University of Pittsburgh make up the Appalachian Tri State Node within the Community Trials Network. The network also dedicates itself to multi-site studies as well as the transfer of research outcomes and evidence based treatments to community treatment providers .

Current Addiction Related Research Projects

A Two Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment plus Individual Drug Counseling for Opioid Analgesic Dependence.
Principle Investigator:  Mimmie Byrne, LICSW, CAC; Co-Investigators: Carl Rollynn Sullivan, MD, James Berry, DO, Paul Clausell, MD

Objective: To determine whether the addition of individual drug counseling to the prescription of Buprenorphine/Naloxone for subjects dependent on prescription opioid analgesics improves outcome both during a four week outpatient treatment with taper or a 16-week treatment with taper.

This study considers the question about what benefit does individual counseling have over the medical treatment in a brief treatment episode (four weeks) and what benefit does it have in a longer treatment episode (four months).

Do Patients with Opioid Dependence Purchase Prescription Opioids from Cancer Patients: An Epidemiological Study of the Different Sources of Illicit Purchase of Opioids.
Co-PI:  Arvind Vasudevan,MD, Carl Rollynn Sullivan, MD, Mimmie Byrne, LICSW, Bridget Bolasko, MSIV

Opioid Dependent Patients with Chronic Pain: Implications for Treatment of Substance Dependence with Suboxone.
Co-PI’s: Vic Gill, MD, Carl Rollynn Sullivan MD, Mimmie Byrne LICSW, Robert Menguito, MD

Reduction and Enhancement of Psychosocial Functioning Utilizing a Relational Group Treatment Program for Dependent and Co-dependent Persons.
Co-PI:  Mimmie Byrne, LICSW, Robert Edmundson, LICSW, Eric Rankin, Ph.D

Buprenorphine Rescue from Naltrexone Induced Opioid Withdrawal during Relatively Rapid Detoxification from High Dose Methadone
Co-PI: Vanessa Urban, MD, Carl Rollynn Sullivan MD

Opioid Detoxification in Pregnancy Utilizing Codeine Substitution: A Case Series
Co-PI: Susanne Choby MD, Carl Rollynn Sullivan MD

Comparison of Effect of Smoking Cessation Treatments in Recovering Alcoholics and General Smoking Control Groups
Co-PI: Whanhong Zheng MD, Sonja Juneja MD, Saleha Abassi MD, Connie Cerullo MA, Carl Rollynn Sullivan MD